THOUGHTSPOT A ray of hope? Cancer Disappeared Unanticipatedly in Every PatientsBySenior EditorJune 8, 20220Comments
VIEWPOINTS PharmaShots Interview: In Conversation with Portage’s CEO and Director, Dr. Ian Walters, Where he Shares Insights on Ongoing Clinical-Stage and Development ProgramsBySenior EditorJune 8, 20220Comments
THOUGHTSPOT Accelerating the Transition Between Antibody Research and ProductionBySenior EditorJune 7, 20220Comments
VIEWPOINTS PharmaShots Interview: In Conversation with Cidara’s CEO, Dr.Jeff Stein, Where he Shares Insights on the IND acceptance by the FDA to Treat InfluenzaBySenior EditorJune 6, 20220Comments
VIEWPOINTS PharmaShots Interview: In Conversation with Amolyt’s CEO, Thierry Abribat, Where he Shares Insights on Amolyt as a Key Player in Hypoparathyroidism SpaceBySenior EditorJune 1, 20220Comments
VIEWPOINTS PharmaShots Interview: In Conversation with Pyxis’ CMO Jay M. Feingold, Where he Shares Insights on the addition of In-Licensed & Internal IO AssetsBySenior EditorMay 31, 20220Comments
VIEWPOINTS PharmaShots Interview: MindMed’s Robert Barrow Shares Insights on Study to show Key Differences Between LSD and PsilocybinBySenior EditorMay 30, 20220Comments
